SACTSONJ
REGN icon

Supplemental Annuity Collective Trust (SACT) of New Jersey’s Regeneron Pharmaceuticals REGN Stock Holding History

Supplemental Annuity Collective Trust (SACT) of New Jersey’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$400K Sell
641
-41
-6% -$27.9K 0.1% 190
2026
Q1 		$527K Buy
+682
New +$522K 0.15% 137

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Amundi
Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Supplemental Annuity Collective Trust (SACT) of New Jersey's REGN Position: Q2 2026 in Review

Supplemental Annuity Collective Trust (SACT) of New Jersey reduced its Regeneron Pharmaceuticals (REGN) stake by 6% in Q2 2026, selling an estimated $27.9K and leaving 641 shares worth $400K. The position accounts for 0.1% of the portfolio, ranked #190.

Supplemental Annuity Collective Trust (SACT) of New Jersey first reported a position in REGN in Q1 2026 and has held it in 2 quarters since. The position peaked at $527K in Q1 2026. 955 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Supplemental Annuity Collective Trust (SACT) of New Jersey held 641 shares of Regeneron Pharmaceuticals worth $400K as of Q2 2026.
  • Supplemental Annuity Collective Trust (SACT) of New Jersey sold 41 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $27.9K.
  • Regeneron Pharmaceuticals made up 0.1% of Supplemental Annuity Collective Trust (SACT) of New Jersey's portfolio in Q2 2026, its #190 holding.
  • Supplemental Annuity Collective Trust (SACT) of New Jersey first reported a position in Regeneron Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • Supplemental Annuity Collective Trust (SACT) of New Jersey's Regeneron Pharmaceuticals position peaked at $527K in Q1 2026.
  • 955 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Supplemental Annuity Collective Trust (SACT) of New Jersey's 13F filing for Q2 2026, filed 27 Jul 2026.